Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

BiomeBank

Request full access

A clinical stage biotechnology company developing microbial therapies

Adelaide, AustraliaFounded 2018Biotech & Life Sciences

About BiomeBank

BiomeBank is a leading microbiome therapeutics company with a mission to restore human gut microbial ecology. BIOMICTRA,TM is the first approved donor derived microbiome therapy in the world (approved by TGA in 2022 for C.difficile infection). BiomeBank’s CONSORTIOMETM drug development platform, leverages data from BIOMICTRA use in discovery trials in novel disease indications to create therapies disease specific cultured microbiome based therapies. The CONSORTIOME TM platform contains the ability to co-culture >100 of the most prevalent species covering >90% of known gene families in a healthy human gut microbiome into one drug substance. Cultured therapy BB265 has been designed to treat ulcerative colitis and will enter a phase 1b/2a human study in 2025. Due to similar disease mechanisms, BB265 is expected to also have efficacy in treating Crohn’s disease. In addition, BB128 is being positioned for orphan disease indicaton and discovery trials are underway in 4 other novel disease indications.

Source: Dealroom company data

At a glance

Status
Operational
Employees
38
Open positions
None listed
Dealroom signal
81.2/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotechnology, Microbiome, Spinout, Biotech and Pharma, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B

Funding history

9 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
GROWTH EQUITY VC✓Equity / VC Apr 2026 $9.7M $45M Blackmores ↗
SECONDARY✓Other financing Mar 2024 $3.9M — South Australian Venture Capital Fund · Artesian Capital Management —
Showing the latest 2 of 9 recorded eventsBook a demo for the full funding history →

Growth signals

BiomeBank website traffic

Latest recorded traffic for BiomeBank is 5.1K monthly website visits, up 59.4% over the last three months. BiomeBank's team grew 2.7% over the past year.

Latest monthly visits5.1K 3-month web change+59.4% 1-year team growth+2.7%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

BiomeBank in the Adelaide ecosystem

Live from Dealroom

The BiomeBank office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

9 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed3 investors entered at this stage

  • The Hospital Research Foundation
  • Government of South Australia
  • Innovation Connections

Series A4 investors entered at this stage

  • Artesian Capital Management
  • Ellerston Capital
  • South Australian Venture Capital Fund
  • Chapman Capital Partners

Series B and later1 investor entered at this stage

  • Blackmores

Other known investors1 additional known investor

  • University of Adelaide
Team profiled 8 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 4 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
3 countries with
team presence
🇦🇺 Australia87.5%
🇺🇸 United States9.4%
🇨🇦 Canada3.1%
3 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about BiomeBank on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See BiomeBank’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.